---
title: "Allianz Global Investors Takes 6.85% Stake in Uniphar"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278882148.md"
description: "Allianz Global Investors GmbH has acquired a 6.85% stake in Uniphar PLC, holding 17,776,553 ordinary shares as of March 11, 2026. This significant shareholding reflects strong institutional interest in Uniphar, potentially enhancing its capital markets profile. The move is seen as a vote of confidence in Uniphar's strategy and long-term prospects, which may influence the company's governance and strategic direction. Uniphar is an Ireland-based healthcare services company operating in the pharmaceutical and medical sectors, providing distribution and support services."
datetime: "2026-03-12T12:17:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278882148.md)
  - [en](https://longbridge.com/en/news/278882148.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278882148.md)
---

# Allianz Global Investors Takes 6.85% Stake in Uniphar

### Claim 70% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Uniphar PLC ( (GB:UPR) ) has shared an announcement.

Uniphar plc disclosed that Allianz Global Investors GmbH has built a significant shareholding in the company, holding 17,776,553 ordinary shares as of 11 March 2026. This stake represents 6.85% of Uniphar’s issued share capital, indicating a notable level of institutional investor interest in the group and potentially strengthening its capital markets profile.

The increased holding by Allianz Global Investors may be interpreted as a vote of confidence in Uniphar’s strategy and long-term prospects. It also modestly reshapes the company’s shareholder base, a development that existing investors and market observers may watch closely for any future governance or strategic implications.

**More about Uniphar PLC**

Uniphar plc is an Ireland-based healthcare services company that operates across the pharmaceutical and medical sectors. The group typically focuses on providing distribution, commercial, and related support services to manufacturers and healthcare providers in domestic and international markets.

See more insights into UPR stock on TipRanks’ Stock Analysis page.

## Related News & Research

- [Softlab publishes 2026 remuneration policy, discloses 2025 pay report](https://longbridge.com/en/news/287656909.md)
- [BULGOLD Announces Annual General and Special Meeting Voting Results](https://longbridge.com/en/news/287551964.md)
- [Blue Jet Healthcare Clears FY26 Results, Dividend and Rs 10 Billion Fund-Raising Plan](https://longbridge.com/en/news/287505675.md)
- [ZAWYA: UAE’s Arada targets 800-bed healthcare network with $545mln investment](https://longbridge.com/en/news/287505662.md)
- [Kepler Group, Hong Kong Insurance Brokerage, Files for Nasdaq Capital Market IPO](https://longbridge.com/en/news/287406723.md)